A detailed history of South State Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, South State Corp holds 14 shares of CRL stock, worth $2,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Previous 79 82.28%
Holding current value
$2,082
Previous $11,000 81.82%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

SELL
$99.75 - $151.89 $6,483 - $9,872
-65 Reduced 82.28%
14 $2,000
Q1 2025

May 12, 2025

BUY
$150.52 - $190.14 $7,526 - $9,507
50 Added 172.41%
79 $11,000
Q4 2024

Feb 10, 2025

BUY
$178.58 - $220.69 $5,178 - $6,400
29 New
29 $5,000
Q2 2022

Aug 05, 2022

BUY
$204.13 - $302.4 $8,165 - $12,096
40 New
40 $9,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $7.57B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track South State Corp Portfolio

Follow South State Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.